
Sign up to save your podcasts
Or


When it comes to cancer care, we know about chemotherapy, surgery, bone marrow transplants and even the coming of stem cell therapies. But should hope also be included as a treatment for these life threatening diseases? Dr. Edgar Staren, senior vice president for clinical affairs and chief medical officer at Cancer Treatment Centers of America speaks to the Chicago Tribune's Bruce Japsen about this important consideration.
The customer is often first when seated at a restaurant table or when he or she walks into the lobby of the Ritz Carlton, but such an experience can still be a new phenomenon in health care. Dr. Edgar Staren, Senior Vice President for Clinical Affairs and Chief Medical Officer at Cancer Treatment Centers of America tells the Chicago Tribune's Bruce Japsen how these hospitals provide customer-friendly care with specialized food, massage therapies and alternative treatments to complement the traditional chemotherapy and cancer treatment regimens.
Consumers are demanding high-quality healthcare at a reasonable price. How can we work with them to ensure the emergence of this ideal scenario? Dr. Mark Chassin, president of the Joint Commission, tells host Bruce Japsen about payment schemes linked to standardized measures, and tactics to reduce overuse of services, among other strategies to broaden the debate over quality and affordability in modern healthcare.
How should quality standards be integrated into the national debate on health care reform? Dr. Mark Chassin, president of the Joint Commission, tells host Bruce Japsen how we can address health care quality, one of the major challenges facing the medical system in the United States.
Where do we draw the line when it comes to usage of medical care services? The Joint Commission's President, Dr. Mark Chassin, examines how health care providers need to look at their services from three critical angles: overuse, underuse, and misuse. Bruce Japsen hosts.
They say a man is as old as his arteries. We can now tell our patients just how old they are with the FDA-approved Endopat2000, a noninvasive device that safely and quickly measures endothelial function and can help monitor response to treatment or interventions. Join host Dr. Larry Kaskel talking with Dr. Amir Lerman to learn more about measuring endothelial function.
From the publisher's feed

7,978 Listeners

29,181 Listeners